NJ-based Advanced Nutraceuticals has withdrawn its Sept. 16 IPO filing valued at about $69 million. The company planned to acquire its four founding companies—NJ-based Quality Botanical Ingredients, CA-based ACTA Products and Northridge Laboratories, and NY-based Bactolac Pharmaceu-ticals—concurrent with the IPO’s completion.